New hope for lung cancer patients with ground-breaking treatment option to be listed on the PBS
Australians with non-small cell and small cell lung cancer or chronic obstructive pulmonary disease (COPD) will benefit from new and expanded treatment options on the Pharmaceutical Benefits Scheme (PBS) from 1 March 2020. The Morrison Government is listing Imfinzi® (durvalumab) for the first time for the treatment of non‑small cell lung cancer for patients who…